People with long COVID are at increased risk of developing cardiovascular disease, according to a new study from Karolinska Institutet published in eClinicalMedicine. The results show that the risk of conditions such as cardiac ...
Apr 1, 2026
0
16
A global research team co‑led by McMaster University has identified one of the first medications shown to meaningfully reduce fatigue in people living with long COVID—a breakthrough for millions still struggling with persistent ...
Mar 31, 2026
0
11
A variant of COVID-19 called BA.3.2, which has circulated under the radar since late 2024, is now spreading quickly across the United States. As a pulmonary and critical care doctor, I see many patients who are at high risk ...
Mar 30, 2026
0
9
A growing body of evidence suggests that long COVID (or post-COVID syndrome), a condition affecting more than 10% of people after a SARS-CoV-2 infection, may be driven by the immune system turning against the body. Now, new ...
Mar 24, 2026
0
49
Nearly three years since the SARS-CoV-2 pandemic was declared over, conservative estimates suggest that between 80 million and 400 million people worldwide have long COVID. This chronic condition associated with the infection ...
Mar 23, 2026
0
41
Nurses working during the COVID-19 pandemic in Wales experienced high levels of moral distress, strongly associated with depression and linked to intentions to leave the profession, according to a new study led by Cardiff ...
Mar 16, 2026
0
8
In a large, randomized trial, researchers at Mass General Brigham found that high-dose vitamin D3 did not reduce COVID-19 infection severity, but may impact long COVID outcomes. Results of the study are published in The Journal ...
Mar 12, 2026
0
12
For people who have recovered from diagnoses characterized by persistent fatigue, a new understanding of symptoms seems to have been key to recovery. This is the conclusion of a study from Linköping University, Sweden. The ...
Mar 10, 2026
0
11
New research from The Ohio State University College of Medicine is the first to objectively measure multisensory losses in COVID-19 patients. "Our goal is to understand why some long COVID patients experience different profiles ...
Mar 5, 2026
0
20
The search for long COVID treatments continues, as a randomized clinical trial found that a two-week course of metformin or ursodeoxycholic acid (UDCA) did not meaningfully improve recovery from symptoms, despite earlier ...
Mar 3, 2026
0
14
